5-MAPB, also known as '5-(N-methyl-2-aminopropyl)benzofuran', is an entactogen and designer drug of the amphetamine family that is similar to MDMA in its structure and effects.
5-MAPB, also known as '5-(N-methyl-2-aminopropyl)benzofuran', is an entactogen and designer drug of the amphetamine family that is similar to MDMA in its structure and effects.
5-MAPB was first encountered as a novel designer drug in 2013 and described in the scientific literature in 2014. It has been patented by Tactogen as an entactogen for potential use as a medicine.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).